Measuring comorbidity and overlap in the hospitalization cost for alcohol and drug abuse and mental illness
- PMID: 2526093
Item in Clipboard
Measuring comorbidity and overlap in the hospitalization cost for alcohol and drug abuse and mental illness
Inquiry.
1989 Summer.
Abstract
This paper measures the cost of short-stay hospitalization in 1985 for alcohol and drug abuse and mental illness (ADM). We identify and quantify two measurement problems: comorbidity in which ADM disorders may play a secondary role to other diagnoses and "overlap" in which ADM disorders occur together. Using data from the National Hospital Discharge Survey, we estimate the ADM short-stay hospital costs to total $13.1 billion. Almost four-fifths are costs of care for patients with primary ADM diagnoses and the remaining one-fifth is attributed to ADM comorbidity. About one-fifth of both the ADM discharges and the days of care represent overlap for hospitalized patients.
Similar articles
-
Data watch. What is the cost of ADM (alcohol and drug abuse and mental health) in the U.S.?Behav Healthc Tomorrow. 1998 Apr;7(2):18-9, 31. Behav Healthc Tomorrow. 1998. PMID: 10178432 No abstract available.
-
Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.J Ment Health Policy Econ. 2003 Mar;6(1):3-12. J Ment Health Policy Econ. 2003. PMID: 14578543
-
Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.Stat Bull Metrop Insur Co. 1999 Oct-Dec;80(4):2-9. Stat Bull Metrop Insur Co. 1999. PMID: 10553265
-
Mental illness and the economy.Bull Pan Am Health Organ. 1984;18(4):364-70. Bull Pan Am Health Organ. 1984. PMID: 6395932 Review. No abstract available.
-
Conceptual framework for estimating the social cost of drug abuse.J Health Soc Policy. 1991;2(3):1-22. doi: 10.1300/J045v02n03_01. J Health Soc Policy. 1991. PMID: 10170913 Review.
Cited by
-
Supplemental Security Income (SSI), Disability Insurance (DI), and substance abusers.Community Ment Health J. 1998 Aug;34(4):337-50. doi: 10.1023/a:1018779805833. Community Ment Health J. 1998. PMID: 9693863
-
A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.Addiction. 2016 Aug;111(8):1406-15. doi: 10.1111/add.13363. Epub 2016 Apr 21. Addiction. 2016. PMID: 26918564 Free PMC article. Clinical Trial.
-
A patient-based analysis of drug disorder diagnoses in the Medicare population.Health Care Financ Rev. 1993 Winter;15(2):89-101. Health Care Financ Rev. 1993. PMID: 10171899 Free PMC article.
-
Alcohol drinking patterns and medical care use in an HMO setting.J Behav Health Serv Res. 2000 Feb;27(1):3-16. doi: 10.1007/BF02287800. J Behav Health Serv Res. 2000. PMID: 10695237
-
Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990.Am J Public Health. 1994 Sep;84(9):1433-8. doi: 10.2105/ajph.84.9.1433. Am J Public Health. 1994. PMID: 8092367 Free PMC article.